The Serum C-reactive Protein and Prooxidant-antioxidant Balance in Patients with Esophageal Cancer Compared to Healthy Subjects

  • سال انتشار: 1393
  • محل انتشار: مجله پزشکی قلب و قفسه سینه، دوره: 2، شماره: 1
  • کد COI اختصاصی: JR_JCTM-2-1_004
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 372
دانلود فایل این مقاله

نویسندگان

Ali Taghizadeh Kermani

۱Oncologist, Cardio-Thoracic Surgery & Transplant Research Center, Emam Reza hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Sara Esmaeeli

Addiction Research Center, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

Rozita Vakili

Addiction Research Center, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

Seyed Isaac Hashemy

Clinical Biochemistry Specialist ,Surgical Oncology Research Center, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

چکیده

Introduction: The molecular mechanisms involved in pathogenesis of esophageal cancer have been the main concern of several studies. In this study, we aimed to investigate the changes of serum prooxidant-antioxidant balance (PAB) value as a redox index, as well as serum C-reactive protein (CRP) compared to healthy control group. Materials and Methods: In a cross-sectional study, blood samples were drawn from 25 patients with esophageal cancer and 25 healthy subjects. Serum CRP and PAB value were measured in all samples according to relevant protocols. Results: Serum CRP was significantly higher in our patients (14.3 ± 3.2 mg/L) compared to healthy control group (4.6 ± 1.4 mg/L), with a p-value of less than 0.001. The value of PAB in our patients (133.9 ± 21.7) was also higher than that of healthy subject (51.3 ± 11.2), indicating a redox perturbation in favor of oxidants. Conclusion: There was a significant increase in both serum PAB value and CRP in patients with esophageal cancer compared to the control group, which indicated both oxidative stress and inflammatory response in patients with esophageal cancer, respectively.

کلیدواژه ها

Antioxidant, CRP, Esophageal Cancer, Oxidative stress, Pro-oxidant

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.